二(o-溴苄基)锡双(二乙基二硫代氨基甲酸)酯和二(o-氯苄基)锡双(吡咯啶二硫代氨基甲酸)酯的合成、结构及体外抗癌活性研究

二(o-溴苄基)二溴化锡和二(o-氯苄基)二氯化锡分别与N,N-二乙基二硫代氨基甲酸钠和吡咯啶二硫代氨基甲酸钠反应,合成了二(o-溴苄基)锡双(二乙基二硫代氨基甲酸)酯(1)和二(o-氯苄基)锡双(吡咯啶二硫代氨基甲酸)酯(2)。用X-射线单晶衍射测定了两个化合物的晶体结构,测试结果表明:化合物1的晶体为单斜晶系,空间群P21/c,晶体学参数a=1.827 36(4)nm,b=0.900 60(2)nm,c=1.988 41(5)nm,β=114.878 0(10)°,V=2.968 71(12)nm3,Z=4,Dc=1.690 g·cm-3,μ(Mo Kα)=38.50 cm-1,F(000)=1 496,R1=0.051 6,wR2=0.154 6。化合物2的晶体为单斜晶系,空间群C2/c,晶体学参数a=2.241 28(4)nm,b=0.818 78(2)nm,c=1.542 69(3)nm,β=106.787 0(10)°,V=2.710 37(10)nm3,Z=4,Dc=1.623 g·cm-3,μ(Mo Kα)=14.65 cm-1,F(000)=1 336,R1=0.022 9,wR2=0.056 5。晶体中锡原子呈六配位畸变八面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了配合物的热稳定性和体外抗癌活性。     

三(o-溴苄基)锡吡咯烷基二硫代甲酸酯的合成、结构及体外抗癌活性

利用三(o-溴苄基)溴化锡与吡咯烷基二硫代甲酸钠反应,合成了三(o-溴苄基)锡吡咯烷基二硫代甲酸酯。用X射线单晶衍射测定了其晶体结构,化合物为三斜晶系,空间群P1,晶体学参数a=0.91354(11)nm,b=1.07313(13)nm,c=1.52677(18)nm,α=75.440(6)°,β=89.499(6)°,γ=72.515(7)°,V=1.3781(3)nm3,Z=2,Dc=1.868 g/cm3,μ(MoKα)=54.43 cm-1,F(000)=752,R1=0.0320,wR2=0.0765。化合物中的锡原子为四配位畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了配合物体外抗癌活性。     

三(3,5-二甲基苄基)氯化锡和四(间氰基苄基)锡的合成、晶体结构和量子化学研究

以3,5-二甲基苄基氯和间氰基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二甲基苄基)氯化锡(1)和四(间氰基苄基)锡(2),经X射线衍射方法测定了化合物的晶体结构。化合物1属单斜晶系,空间群为P21/m,晶体学参数:a=0.584 03(4)nm,b=1.966 37(14)nm,c=0.856 46(5)nm,β=95.138(3),V=0.979 62(11)nm3,Z=2,Dc=1.735 g·cm-3,μ(Mo Kα)=14.53 cm-1,F(000)=524,R1=0.043 7,w R2=0.123 2。化合物2属单斜晶系,空间群为C2/c,晶体学参数:a=1.692 21(12)nm,b=1.167 41(8)nm,c=1.539 41(11)nm,β=116.615(10)°,V=2.718 9(3)nm3,Z=4,Dc=1.424 g·cm-3,μ(Mo Kα)=9.67cm-1,F(000)=1 176,R1=0.017 5,w R2=0.046 1;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。     

三(邻甲基苄基)氯化锡和二(对甲基苄基)二氯化锡的合成和晶体结构

将邻甲基氯苄和对甲基氯苄在适当的溶剂中与锡粉反应，合成了三(邻甲基苄基)氯化锡1和二(对甲基苄基)二氯化锡2，用X射线衍射方法测定了化合物的晶体结构。化合物(1)的晶体属三方晶系，空间群为R3，晶体学参数：a=1.329 36(8) nm，b=1.329 36(8) nm，c=2.147 0(3) nm，α=β=90°，γ=120°，V=3.285 8(5) nm³，Z=6，D_c=1.424 g·cm^-3，μ(Mo Kα)=12.93 cm^-1，F(000)=1 428，R₁=0.037 1，wR=0.110 2。化合物2的晶体属单斜晶系，空间群为C2/c，晶体学参数：a=2.850 4(3) nm，b=0.491 23(5) nm，c=1.215 32(12) nm，β=112.517(2)°，V=1.571 9(3) nm³，Z=4，D_c=1.690 g·cm^-3，μ(Mo Kα)=19.49 cm^-1，F(000)=792，R₁=0.038 0，wR₂=0.109 4；中心锡原子为畸变四面体配位构型。     

三(邻甲基苄基)锡和二(间氟苄基)锡硫代水杨酸酯配合物的合成、结构及性质

合成了三(邻甲基苄基)锡硫代水杨酸酯配合物(1)和一维链状二(间氟苄基)锡硫代水杨酸酯配合物(2),经元素分析、IR、NMR、X射线衍射等技术手段表征了其结构。配合物1属三斜晶系,空间群Pī,晶体学参数a=1.00221(5)nm,b=1.48934(8)nm,c=1.71789(9)nm,α=78.3120(10)°,β=85.6560(10)°,γ=80.2580(10)°,V=2.4725(2)nm~3,Z=2,Dc=1.371 g/cm~3,μ(Mo Kα)=10.91 cm~(-1),F(000)=1040,R_1=0.0439,wR_2=0.1119。配合物2属单斜晶系,空间群为P21/n,晶体学参数:a=1.17827(5)nm,b=2.11945(9)nm,c=1.55970(7)nm,β=93.4510(10)°,V=3.8880(3)nm~3,Z=4,Dc=1.671 g/cm~3,μ(Mo Kα)=14.53 cm~(-1),F(000)=1936,R1=0.0323,wR2=0.0927。配合物1中锡原子呈四配位畸变四面体构型,配合物2中锡原子呈五配位畸变三角双锥构型。配合物1和2分别在152和195℃下稳定,电化学性质不可逆,对人体癌细胞Colo205、Hep G2、MCF-7、Hela和NCI-H460具有体外抗癌活性,配合物2的抗癌活性远大于配合物1。     

三(3,5-二氟苄基)氯化锡和四(邻氯苄基)锡的合成、晶体结构及量子化学

3,5-二氟苄基氯和邻氯基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二氟苄基)氯化锡(1)和四(邻氯苄基)锡(2),经X射线衍射方法测定了新化合物的晶体结构。化合物1属单斜晶系,空间群为C2/c,晶体学参数:a=1.858 33(11)nm,b=1.140 98(7)nm,c=2.690 06(16)nm,β=109.288(10)°,V=5.383 6(6)nm3,Z=8,Dc=1.532 g·cm~(-3),μ(Mo Kα)=13.61 cm~(-1),F(000)=2 480,R1=0.085 1,wR~2=0.168 1。化合物2属单斜晶系,空间群为P21/m,晶体学参数:a=0.585 54(5)nm,b=1.969 74(18)nm,c=0.857 86(8)nm,β=95.204 0(10)°,V=0.985 34(15)nm3,Z=2,Dc=1.805 g·cm~(-3),μ(Mo Kα)=14.91 cm-1,F(000)=524,R1=0.054 0,wR_2=0.163 9;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了化合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了化合物的热稳定性。     

二苄基锡N,N-二甲基氨荒酸酯的合成及晶体结构

利用二苄基二氯化锡和N, N-二甲基氨荒酸钠反应, 合成了二苄基锡N, N-二甲基氨荒酸酯(C20H26N2S4Sn, Mr = 541.36)。通过元素分析、红外光谱、核磁共振氢谱和质谱对其结构进行了表征。用X-射线单晶衍射测定了该化合物的晶体结构。化合物为单斜晶系, 空间群P21/n, a = 1.3926(5), b = 0.9832(4), c = 1.7080(7) nm, b = 103.541(6), V = 2.274(2) nm3, Z = 4, Dc = 1.581 g/cm3, m(MoKa) = 1.500 mm-1, F(000) = 1096, R = 0.0482, wR = 0.1162. 在化合物的晶体中, 锡原子为六配位的畸变八面体构型。     

三(3,5-二甲基苄基)氯化锡和四(间氰基苄基)锡的合成、晶体结构和量子化学研究

以3,5-二甲基苄基氯和间氰基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二甲基苄基)氯化锡(1)和四(间氰基苄基)锡(2),经X射线衍射方法测定了化合物的晶体结构。化合物1属单斜晶系,空间群为P2₁/m,晶体学参数:a=0.584 03(4) nm,b=1.966 37(14) nm,c=0.856 46 (5) nm, β=95.138(3), V=0.979 62(11) nm³,Z=2,D_c=1.735 g·cm^-3,μ(Mo Kα)=14.53 cm^-1,F(000)=524,R₁=0.043 7,wR₂=0.1232。化合物2属单斜晶系,空间群为C2/c,晶体学参数:a=1.692 21(12) nm,b=1.167 41(8) nm,c= 1.539 41(11) nm,β=116.615(10)°,V=2.718 9(3) nm³,Z=4,D_c=1.424 g·cm^-3,μ(Mo Kα)=9.67cm^-1,F(000)=1 176,R₁=0.017 5,wR₂=0.046 1;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。     

二(对-氯苄基)二氯化锡的合成及晶体结构

用 X射线方法测定了二 (对氯苄基 )二氯化锡的晶体结构,该化合物晶体属单斜晶系,空间群为 C2/c,晶体学参数： a=2.8010(3), b=0.4882(2), c=1.2174(3)nm,β =111.71(1)°, V=1.5467(7) nm3, Z=4, Dx=1.893g· cm－ 3,μ (MoKα )=23.24cm－ 1, F(000)=856.00, R=0.025, Rw=0.038, Sn C键长为 0.2148(3)nm, Sn Cl键长为 0.23754(9)nm。空间构型为畸变四面体构型的单分子有机锡化合物。     

二(对氯苄基)锡双吗啉氨荒酸酯和二(对氯苄基)氯化锡N,N-二乙基氨荒酸酯的合成、表征及晶体结构

利用二(对氯苄基)二氯化锡和吗啉氨荒酸钠、N,N-二乙基氨荒酸钠反应,合成了二(对氯苄基)锡双吗啉氨荒酸酯C24H28Cl2N2O2S4Sn (Mr = 694.31) 1和二(对氯苄基)氯化锡N,N-二乙基氨荒酸酯C19H22Cl3NS2Sn (Mr = 553.54) 2。用X-射线单晶衍射测定了这2个化合物的晶体结构,测试结果表明:化合物1的晶体为单斜晶系,空间群C2/c, a = 21.998(9), b = 6.469(3), c = 20.204(8) ,β= 94.444(6)o , Z = 4, V = 2866.3(19) 3, Dc = 1.609 g/cm3, μ(MoKα) = 1.394 mm-1, F(000) = 1400,S = 0.955, (?)max = 0.000,R = 0.0389, wR = 0.0817。化合物2的晶体为单斜晶系,空间群P21/c, a = 13.088(10), b = 9.304(7), c = 19.593(14) ,β = 107.158(10)o, Z = 4, V = 2280(3) 3, Dc = 1.613 g/cm3,μ(MoKα) = 1.660 mm-1, F(000) = 1104,S = 1.010, (?)max = 0.001,R = 0.0290, wR = 0.0651。在化合物1中,锡原子呈六配位畸变八面体构型, 化合物2的锡原子则是五配位畸变三角双锥构型。     

Synthesis and Crystal Structure of a Novel Monomeric Di-butyltin Dicarboxylate: nBu2Sn[O2CCH2CH(4-ClC6H4)Ge(OCH2CH2)3N]2.H2O

nBu2Sn[O2CCH2CH(4-ClC6H4)Ge(OCH2CH2)3N]2.H2O(Mr=1053.66) is an air-stable compound which crystallizes in the monoclinic space group C2/c with a=21.182(5), b=12.174(3), c=17.108(4) , β=99.59(2)°, V=4350(3) 3, Z=4, F(000)=2104, μ=2.104 mm-1. The refinement of structure with I≥3σ(I) for 1819 reflections converged at R=0.045. The coordination geometry around the Sn atom is best described as an askew-pentagonal bipyramid, in which four carboxylate oxygen atoms( Sn(1)-O(5), Sn(1)-O(5a)=2.099 and Sn(1)-O(4), Sn(1)-O(4a)=2.158 ) and an oxygen atom from an aqua ligand comprise the pentagonal plane, with two butyl groups occupying axial positions.     

七配位二聚体配合物{(PhCH2)2Sn·[2,6-(O2C)2C5H3N](CH3OH)}2的合成及结构

在三乙胺存在下利用三苄基氯化锡和2,6-吡啶二甲酸,以1:1摩尔比反应,合成了七配位二聚体{(PhCH2)2Sn[2,6-(O2C)2C5H3N](CH3OH)}2.通过元素分析、红外光谱和核磁共振氢谱对其结构进行了表征.用X射线单晶衍射法测定了该化合物的晶体结构.化合物为三斜晶系,P1空间群,晶胞参数a=0.9625(6)nm,b=1.0947(9)nm,c=1.996(3)nm,α=90.00(2)°,β=87.69(3)°,γ=90.00(3)°,Z=2,V=2.102(6)nm3,μ=1.248mm-1,F(000)=1000,R1=0.0476,wR2=0.0782.化合物中2个锡原子呈七配位畸变五角双锥构型.生物活性测试结果表明,该化合物具有较强的体外抗肿瘤活性.     

鼓形有机锡氧杂环羧酸簇合物[PhCH2Sn(O)(O2CC4H3S)]6·2CH2Cl2 和 [PhCH2Sn(O)(O2CC3H2NO)]6·2CH2Cl2的合成和晶体结构

利用三苄基氧化锡与2-噻吩甲酸和2-唑甲酸反应,合成了六聚体苄基锡氧2-噻吩甲酸酯(1)和六聚体苄基锡氧2-唑甲酸酯(2)鼓形簇合物.通过元素分析、红外光谱和X射线单晶衍射对其结构进行了表征.测试结果表明:化合物1属三斜晶系,空间群p1,a=1.2760(3)nm,b=1.3056(3)nm,c=1.3343(3)nm,α=105.65(3)°,β=96.27(3)°,γ=97.20(3)°,Z=1,V=2.0997(7)nm3,Dc=1.809g/cm3,μ=2.097mm-1,F(000)=1116,R=0.0651,wR=0.1292.化合物2属三斜晶系,空间群p1,a=1.2240(4)nm,b=1.3673(4)nm,c=1.3744(4)nm,α=107.760(4)°,β=98.069(5)°,γ=91.480(5)°,Z=2,V=2.1631(12)nm3,Dc=3.373g/cm3,μ=3.799mm-1,F(000)=2136,R=0.0382,wR=0.079.它们均为鼓形簇状结构,锡原子呈畸变的八面体构型.化合物1通过分子间S…S近距离作用,形成一维链状结构.     

新型鼓状有机锡氧杂环羧酸簇合物[PhCH2Sn(O)(O2CC4H4N)]6·2CH2Cl2的合成和晶体结构

利用三苄基氧化锡与2-吡咯甲酸反应，合成六聚体-苄基锡氧2-吡咯甲酸酯簇 合物．通过元素分析、红外光谱、核磁共振氢谱和X射线单晶衍射对其结构进行了 表征．X射线单晶衍射测试结果表明：化合物为三斜晶系，空间群P1^-，α＝1． 2644(3)nm，b＝1．7416(4)nm，c＝1．9285(4)nm，α＝90．021(4)°，β＝94． 585(4)°，γ＝90．021(4)°，Z＝2，V＝4．2330(16)nm^3，Dc＝1．715g／cm^3 ，μ＝1．936mm^-1，F(000)＝2136，R＝0．0527，wR＝0．0708．该化合物为鼓型 簇状结构，锡原子为畸变的八面体构型．     

五配位阴离子型有机锡化合物的合成及[C5H5NH][Ph2Sn(μ2-SCH2COO)Cl]和[CH3PhNH2][Ph2Sn(μ2-SCH2COO)Cl]晶体结构

近年来，由于离子型有机锡化合物的分子结构的多样性、较好的生物活性以及在有机合成上的应用，而引起广泛注意，前文报道了Ph3SnCl与HSCH2COOH在有机胺存在下发生Sn-Ph键断裂，生成二苯基锡的离子型有机锡化合物，本文用Ph2SnCl2与HSCH2COOH在有机胺存在下，采用同样的反应条件Sn-Ph键不再断裂，得到与前文结构相类似的化合物，反应方程式如下：     

Synthesis, characterization, and hydrolytic behavior of mixed-ligand diorganotin esters, [R2Sn(O2CR')OSO2Me]2 (R=n-Pr, n-Bu; R'=C9H6N-2, 4-OMe-C9H5N-2, C9H6N-1)

Reactions of the tin precursors, R2Sn(OMe)OSO2Me (R=n-Pr, n-Bu), with an equimolar quantity of 2-quinoline/4-methoxy-2-quinoline/1-isoquinoline carboxylic acid in acetonitrile proceed under mild conditions (rt,12-15 h) via selective Sn-OMe bond cleavage to afford the corresponding mixed-ligand diorganotin derivatives [R2Sn(O2CR')OSO2Me]2 [R'=C9H6N-2, R=n-Pr (1), n-Bu (2); R'=4-OMe-C9H5N-2, R=n-Pr (3), n-Bu (4); R'=C9H6N-1, R=n-Pr (5), n-Bu (6)]. These have been characterized by FAB mass, IR, and multinuclear (1H, 13C, 119Sn) NMR spectral data and X-ray crystallography (for 4 and 6). The molecular structure of 4 (C20H29NO6SSn, monoclinic, P2(1)/n, a=14.1(13) A, b=16.7(18) A, c=20.3(19) A, beta=107(4) degrees, Z=8) comprises distorted octahedral geometry around each tin atom by virtue of weakly bridging methanesulfonate [Sn(1A)-O(3B)=3.010, Sn(1B)-O(3A)=2.984 A] and (N,O) chelation of the carboxylate ligands. The spectral data of 1-4 suggest a similar structural motif in solution. The molecular structure of 6 (C38H53N2O10S2Sn2, monoclinic, P2(1)/c, a=11.339(2) A, b=14.806(3) A, c=24.929(5) A, beta=100.537(3) degrees, Z=4) reveals varying bonding preferences with monomeric units being held together by a bridging methanesulfonate [Sn(2)-O(5)=2.312(2) A] and a carboxylate group bonded to Sn(1) and Sn(2) atoms, respectively. Slow hydrolysis of compound 2 derived from 2-quinoline carboxylic acid in moist CH3CN affords the asymmetric distannoxane, [Bu2Sn(O2CC9H6N-2)-O-Sn(OSO2Me)Bu2]2 (7) (C27H45NO6SSn2, monoclinic, C2/c, a=21.152(3) A, b=13.307(2) A, c=26.060(4) A, beta=110.02(10) degrees, Z=8) featuring ladder type structural motif by virtue of unique mu2-coordination of covalently bonded oxygen atoms [O(6), O(6)#1] of the methanesulfonate groups.     

Synthesis,Crystal Structure and Quantum Chemical Study of the Ladder Organotin Compound {[（C6H5CH2）2Sn]2（O）（Cl2）}2

The title compound {[（C6H5CH2）2Sn]2（O）（Cl2）}2 has been synthesized by the reaction of bisbenzyltin dichloride with NaOH dilute solution, and its structure was determined by X-ray diffraction. The crystal belongs to monoclinic, space group C2/c, with a = 2.5081（17）, b = 1.0089（7）, c = 2.0909（14） nm, β = 94.267（8）°, V= 5.276（6） nm^3, Z = 4, De= 1.734 g/cm^3,μ（MoKa） = 21.55 cm^-1, F（000） = 2704, R = 0.0398 and Rw = 0.1024. According to structural analysis, the tin atom adopts a distorted five-coordinate trigonal bipyramidal geometry, and the ladder-like structure is shaped by one planar four-membered Sn2O2 ring together with two planar four-membered Sn2OCl rings.     

[CH3NH3][NH3(CH2)6NH3]H3[P2Mo2W16O62]·H2O的水热合成与表征

首次合成了[CH3NH3][NH3(CH2)6NH3]H3[P2Mo2W16O62]·H2O,通过元素分析、红外光谱和X射线单晶衍射对合成产物进行了表征,并用TGA-DSC研究了化合物的热稳定性.晶体属单斜晶系,P21/m空间群,a=1.2596(3)nm,b=1.8715(4)nm,c=1.9816(4)nm,α=γ=90°,β=90.16(3)°,V=4.671(2)nm3,Z=2,Mr=4358.66,Dc=3.100g·cm-3,μ=19.978mm-1,F(000)=3792,R=0.0835,Rw=0.2026.结果表明,在晶体结构内形成了0.7364nm×0.8354nm的微孔.     

二正丁基锡水杨醛缩对氨基苯甲酸酯配合物的合成、表征及结构研究

The title complex {[ⁿBu₂Sn(2-OHC₆H₄CH=NC₆H₄COO)]₂O}₂·2H₂O was synthesized by the reaction of N-(4-carboxyphenyl)-salicylideneimine with dibutyltin(IV) oxide in 1∶1 molar ratio. The compound has been characterized by elemental analysis, IR, ¹H NMR spectra and X-ray single crystal diffraction. It crystallizes in triclinic system with space group P1. The crystal data are: a=1.242 9(2) nm, b=1.261 3(2) nm, c=1.594 9(3) nm, α=102.06(2)°, β=92.884(3)°, γ=95.939(3)°, Z=2, D_c=1.342 g·cm^-3, F(000)=1 000, V=2.425 2(7) nm³, R₁=0.041 5, wR₂=0.104 4. The compound is in centro-symmetric dimer structure mode with a four-member central endo-cyclic Sn₂O₂ unit in which the bridging oxygen atoms are tri-coordinated. All the tin atoms are five-coordinated with geometry of distorted trigonal bipyramid. CCDC:286105.